Related references
Note: Only part of the references are listed.Defining clinically significant prostate cancer on the basis of pathological findings
Andres Matoso et al.
HISTOPATHOLOGY (2019)
Prostate MRI, with or without MRI-targeted biopsy, and systematic biopsy for detecting prostate cancer
Frank-Jan H. Drost et al.
COCHRANE DATABASE OF SYSTEMATIC REVIEWS (2019)
Clinical utility of the Prostate Health Index (phi) for biopsy decision management in a large group urology practice setting
Jay White et al.
PROSTATE CANCER AND PROSTATIC DISEASES (2018)
Combining Prostate Health Index density, magnetic resonance imaging and prior negative biopsy status to improve the detection of clinically significant prostate cancer
Sasha C. Druskin et al.
BJU INTERNATIONAL (2018)
Prospective comparison of PI-RADS version 2 and qualitative in-house categorization system in detection of prostate cancer
Sonia Gaur et al.
JOURNAL OF MAGNETIC RESONANCE IMAGING (2018)
Accuracy of Transperineal Targeted Prostate Biopsies, Visual Estimation and Image Fusion in Men Needing Repeat Biopsy in the PICTURE Trial
Lucy A. M. Simmons et al.
JOURNAL OF UROLOGY (2018)
Prostate Health Index improves multivariable risk prediction of aggressive prostate cancer
Stacy Loeb et al.
BJU INTERNATIONAL (2017)
Performance of PI-RADS version 1 versus version 2 regarding the relation with histopathological results
Thomas Auer et al.
WORLD JOURNAL OF UROLOGY (2017)
Direct comparison of PI-RADS version 2 and version 1 regarding interreader agreement and diagnostic accuracy for the detection of clinically significant prostate cancer
Anton S. Becker et al.
EUROPEAN JOURNAL OF RADIOLOGY (2017)
Diagnostic accuracy of multi-parametric MRI and TRUS biopsy in prostate cancer (PROMIS): a paired validating confirmatory study
Hashim U. Ahmed et al.
LANCET (2017)
Comparison of Prostate Imaging Reporting and Data System Versions 1 and 2 for the Detection of Peripheral Zone Gleason Score 3+4=7 Cancers
Satheesh Krishna et al.
AMERICAN JOURNAL OF ROENTGENOLOGY (2017)
The efficiency of multiparametric magnetic resonance imaging (mpMRI) using PI-RADS Version 2 in the diagnosis of clinically significant prostate cancer
Chenglin Zhao et al.
CLINICAL IMAGING (2016)
PI-RADS Prostate Imaging - Reporting and Data System: 2015, Version 2
Jeffrey C. Weinreb et al.
EUROPEAN UROLOGY (2016)
The Diagnostic Performance of Multiparametric Magnetic Resonance Imaging to Detect Significant Prostate Cancer
J. E. Thompson et al.
JOURNAL OF UROLOGY (2016)
Interobserver Reproducibility of the PI-RADS Version 2 Lexicon: A Multicenter Study of Six Experienced Prostate Radiologists
Andrew B. Rosenkrantz et al.
RADIOLOGY (2016)
Performance Comparison of 1.5-T Endorectal Coil MRI with 3.0-T Nonendorectal Coil MRI in Patients with Prostate Cancer
Zarine K. Shah et al.
ACADEMIC RADIOLOGY (2015)
Can Clinically Significant Prostate Cancer Be Detected with Multiparametric Magnetic Resonance Imaging? A Systematic Review of the Literature
Jurgen J. Futterer et al.
EUROPEAN UROLOGY (2015)
Magnetic Resonance Imaging-targeted Biopsy May Enhance the Diagnostic Accuracy of Significant Prostate Cancer Detection Compared to Standard Transrectal Ultrasound-guided Biopsy: A Systematic Review and Meta-analysis
Ivo G. Schoots et al.
EUROPEAN UROLOGY (2015)
Identification of pathologically insignificant prostate cancer is not accurate in unscreened men
G. L. Shaw et al.
BRITISH JOURNAL OF CANCER (2014)
Characterization of Prostate Lesions as Benign or Malignant at Multiparametric MR Imaging: Comparison of Three Scoring Systems in Patients Treated with Radical Prostatectomy
Tiphaine Vache et al.
RADIOLOGY (2014)
The Prostate Health Index: a new test for the detection of prostate cancer
Stacy Loeb et al.
THERAPEUTIC ADVANCES IN UROLOGY (2014)
Evaluation of [-2] proPSA and Prostate Health Index (phi) for the detection of prostate cancer: a systematic review and meta-analysis
Xavier Filella et al.
CLINICAL CHEMISTRY AND LABORATORY MEDICINE (2013)
ESUR prostate MR guidelines 2012
Jelle O. Barentsz et al.
EUROPEAN RADIOLOGY (2012)
A Multicenter Study of [-2]Pro-Prostate Specific Antigen Combined With Prostate Specific Antigen and Free Prostate Specific Antigen for Prostate Cancer Detection in the 2.0 to 10.0 ng/ml Prostate Specific Antigen Range
William J. Catalona et al.
JOURNAL OF UROLOGY (2011)
[-2]Proenzyme Prostate Specific Antigen is More Accurate Than Total and Free Prostate Specific Antigen in Differentiating Prostate Cancer From Benign Disease in a Prospective Prostate Cancer Screening Study
Brian V. Le et al.
JOURNAL OF UROLOGY (2010)
Comparison of phased-array 3.0-T and endorectal 1.5-T magnetic resonance imaging in the evaluation of local staging accuracy for prostate cancer
Byung Kwan Park et al.
JOURNAL OF COMPUTER ASSISTED TOMOGRAPHY (2007)
Share Paper
